ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2008

Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.

Jason E Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.